COMMUNIQUÉS West-GlobeNewswire

Globus Medical Schedules Third Quarter 2018 Earnings Release and Conference Call
19/10/2018
AUDUBON, Pa., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2018 after [...]
Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in January 2017
19/10/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ("Amarin"), announced today that its wholly owned subsidiary, Corsicanto II Designated Activity Company, a [...]
Correction of Press Release dated September 24, 2018 (‘Golden Leaf Holdings' Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada’)
19/10/2018
TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF) wishes to advise that the press release issued on September 24, 2018 contained an error [...]
GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China
19/10/2018
SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural [...]
Bespoke Extracts Sponsors Motorcycle Racer Sean Dylan Kelly at 35th Annual Race of Champions at Daytona International Speedway
19/10/2018
SUNNY ISLES, Fla., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced that it will be a title sponsor of [...]
Nextech to Offer Educational Sessions and EMR Innovations at AAO 2018
19/10/2018
Nextech to present four in-booth sessions including a panel of electronic medical record (EMR) users to discuss industry trends, new functionalities and more TAMPA, Fla., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Nextech [...]
NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMO
19/10/2018
NANOBIOTIX: POSITIVE PHASE II/III RESULTS FOR NBTXR3 IN SOFT TISSUE SARCOMA PRESENTED AT ESMO Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class [...]
NANOBIOTIX : Résultats positifs de la Phase II/III dans les Sarcomes des Tissus Mous avec NBTXR3 présentés à l’ESMO
19/10/2018
NANOBIOTIX : RESULTATS POSITIFS DE LA PHASE II/III DANS LES SARCOMES DES TISSUS MOUS AVEC NBTXR3 PRESENTES A L’ESMO Dr. Sylvie Bonvalot, Chef du Service Sarcomes et Tumeurs Complexes de l’Institut Curie (Paris), a [...]
Pediapharm annonce la clôture d’acquisitions transformatrices, de diversification et d’expansion de la plateforme pour une croissance future
19/10/2018
CE COMMUNIQUÉ NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS. NE PAS RESPECTER CETTE CONSIGNE PEUT CONSTITUER UNE VIOLATION DE LA LOI SUR LES TITRES DES ÉTATS-UNIS. MONTRÉAL, 19 [...]
Canntab Files Application to Become Licensed Producer
19/10/2018
TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE:PILL) (“ Canntab ” or the “ Company ”), a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to [...]
Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8
19/10/2018
FARMINGDALE, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC
19/10/2018
Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small cell lung cancer (NSCLC [...]
MediPharm Labs Corp. Bolsters Leadership & Operational Expertise to Further Accelerate Growth
19/10/2018
BARRIE, Ontario, Oct. 19, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“ MediPharm Labs ” or the “ Company ”) (TSXV: LABS) continues to build momentum towards its goal of becoming a global leader in pharmaceutical- [...]
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System
19/10/2018
WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from [...]
Next Green Wave Moves to Acquire Six-Time Cannabis Cup Winning Seed Brand as It Nears Completion of Cultivation Facilities -- CFN Media
19/10/2018
SEATTLE, Wash., Oct. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Shire plc: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks
19/10/2018
CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks - If approved, lanadelumab would be the first monoclonal antibody for the preventive treatment of Hereditary Angioedema (HAE) [...]
Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
19/10/2018
ALPHARETTA, Ga., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
19/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference
19/10/2018
AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and Homocystine AEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a Disease Model of [...]

Pages